Cara Therapeutics Floats New Stock Issue
Cara Therapeutics (NASDAQ: CARA) is tapping the stock market for a round of fresh funding.
The company announced that it has floated a secondary stock issue. Five million shares are to be sold in the offering. It will also grant the issue's underwriters a 30-day option to purchase additional stock, up to 750,000 in total. It did not provide exact timing for the flotation.
Image source: Getty Images
Quelle Fool.com
